The Week Ahead

Stay informed with our weekly buzz about what’s going on in Washington, DC.

Is Bipartisanship Alive?

 Is Bipartisanship Alive? 

While the One Big Beautiful Bill was ultra-partisan, Republicans and Democrats showed they could come together last week when they cleared a first-ever crypto bill.   With the House in this week and the Senate in this week and next, Congress has only a handful of workdays before they head back to their districts and states to connect with constituents.  Can health care policy be bipartisan too?  Let’s find out – welcome to the Week Ahead!  

The Administration  

Things seem a little unsettled over at the Department of Health and Human Services (HHS), with Secretary Robert F. Kennedy Jr. appointing Matt Buckham as acting chief of staff to replace Heather Flick Melanson, who lasted six months in the role.  Buckham is currently Kennedy’s White House liaison for HHS, overseeing recruitment of political appointees with the agency. 

Maybe it’s because there are so many pending lawsuits against HHS?  The administration is appealing a federal court order that blocked the from cutting $11 billion in public health grants. In April, 23 states and DC sued HHS for arbitrarily freezing funds meant for vaccine access, emergency preparedness, mental health and substance abuse programs, and infectious disease tracking. A federal judge in Rhode Island issued a preliminary injunction in May, halting the funding freeze.  

This case, Colorado v. Kennedy, is one of several challenges HHS is facing over federal health funding cuts. In Washington, DC, a separate court granted four municipalities a preliminary injunction over similar infectious disease grant cuts. Meanwhile, a federal judge in Massachusetts vacated Trump-era NIH funding reductions targeting research on gender and diversity, equity, and inclusion. 

The Senate 

Could MilCon-VA be a bellwether of a September shutdown?  The Senate is set to take a critical appropriations vote to fund military construction and the Department of Veterans Affairs, a vote which could offer important insight into the likelihood of a government shutdown at the end of September.  Although the bill advanced unanimously out of committee, a lack of support from Senate Democrats on the floor may indicate broader resistance to cooperating on appropriations.  Prior to passage of President Trump’s recissions request, Senate Minority Leader Chuck Schumer (D-NY) warned that it would “poison” any bipartisan goodwill needed to negotiate the 12 annual spending bills, which need 60 votes to pass the Senate.  Given the backlash Democrats faced from their political base for avoiding a shutdown earlier this year, they may be more willing to let it happen this time —especially in light of Sen. Schumer’s recent warnings. 

The House 

Medicare Advantage is back in the spotlight at a House Ways and Means joint subcommittee hearing on “lessons learned and future opportunities.”  Citing rapid growth and possible need for “targeted improvements,” the hearing could bring out bipartisan interest in addressing coding intensity adjustments, prior authorization, and utilization management.  The committee includes both strong supporters and vocal critics of MA. 

Policymakers are eyeing MA as a possible funding source to pay for health care provisions that are set to expire on September 30 such as telehealth flexibilities and community health center funding.  Given the potentially significant savings involved, physician groups have been hinting at using MA changes to offset the costs of a longer-term “doc fix” or broader physician payment reforms. 

CMS Administrator Mehmet Oz will meet with House Ways and Means Democrats and Republicans on July 23 to discuss agency priorities that fall within the Committee’s jurisdiction.   Certain to come up is the pending $50B rural health transformation fund which states are scrambling to understand how to use to offset expected payment cuts to health care providers from the One Big Beautiful Bill Act. 

Other House Health Care Hearings  

July 22:  House Energy and Commerce Oversight Subcommittee hearing on organ procurement 

There You Have It 

The annual Perseid meteor shower starts this week and will last through August 23.  Caused by Earth passing through the debris of the Swift-Tuttle comet, these meteors are particularly bright and quick.  Did you watch the Perseids when you were a kid?  Aren’t we all still kids at heart?  Let us know!  Make it a great week!  

 

The House is Back in Town

The House is back after a week of celebrating/demagoguing the One Big Beautiful Bill Act (OBBBA) and the Senate has a rescissions package on the table. Meanwhile, the deadlines to fund the government and pass health care extenders are fast approaching.  So, let’s get into it – welcome to the Week Ahead!

The Administration

The Rural Health Transformation Fund is getting all the attention in the newly signed OBBBA, which provides $50B over 5 years to states to improve access, outcomes and financial stability for rural hospitals and other providers.  The fund is meant to blunt the law’s $155B cut in funding over 10 years for rural areas, an estimate from the Kaiser Family Foundation.

With an application deadline of December 31, states, rural health care providers, and other stakeholders are eagerly awaiting guidance from the Centers for Medicare and Medicaid Services (CMS).

Funding for the program can be used for:

  • Payments to health care providers
  • Recruitment and workforce training
  • Purchasing new technologies
  • Supporting access to opioid use disorder treatment and mental health services
  • Promoting evidence-based interventions to improve preventive care and chronic disease management

Food and Drug Administration (FDA) Commissioner Marty Makary is also making news by saying the agency may fast track new drugs from pharmaceutical companies that “equalize” the cost of their medicines between the U.S. and other OPEC countries.  In a Bloomberg Television interview, he floated the idea that price adjustments may give companies another way to obtain vouchers under the National Priority Review Voucher program. The program, launched last month, is designed to shorten the approval process for companies it says are backing national interests.

While Makary described the idea as supporting President Trump’s goal of preventing foreign countries from securing lower drug prices at Americans’ expense, he did not provide details about how drug companies would have to adjust their prices to qualify for a voucher under the program.

This announcement follows the issuance of a May executive order on most-favored nation (MFN) prescription drug pricing and repeated threats to impose tariffs on foreign pharmaceutical products, including a July 8 threat to impose tariffs up to 200% “very soon.” However, this voucher proposal takes a “carrot” approach to pricing that may be more palatable to congressional Republicans who’ve expressed anxiety about MFN and tariffs.

The Senate

The White House is hoping to score another win by passing a $9.4B rescissions package which would make significant cuts to federal HIV funding and global health programs, including $400M from the President’s Emergency Plan for AIDS Relief (PEPFAR).

Despite opposition from certain Senate Republicans about the bill’s impact on domestic HIV prevention and global health diplomacy, as well as on emergency alerts in rural areas if federal funding is eliminated to public broadcasting, the package still has a path forward because Senate rules require only a simple majority to pass it. However, the package faces a strict procedural deadline: it must be passed within 45 days of submission, which in this case would be July 18.

Deja vu all over again?  If the Senate waters down the savings in the bill to accommodate concerns from the Senators mentioned above, it could complicate passage in the House by the deadline, given Freedom Caucus interests in holding firm on the President’s requests for cuts to these programs.

The bigger impact may be on the FY 2026 appropriations process, and the potential for the government to run out of funding on September 30.  In a Dear Colleague, Senate Leader Chuck Schumer (D-NY) called the recissions package “…an affront to the bipartisan appropriations process” and added that it would be “absurd” for GOP lawmakers to then “expect Democrats to act as business as usual and engage in a partisan appropriations process to fund government.”

Senate Health Hearings

  • Senate HELP Nomination Hearing for Assistant Secretary for HHS

The House

With the House only in session for two more weeks before Labor Day, speculation is already growing on how Congress will handle the health care provisions, like Medicare telehealth waivers, that expire with the continuing resolution (CR) on September 30.  Will there be a straight extension of current policy for a few more months, as has been done in the past?  Or will Speaker Mike Johnson (R-LA) try to address health care in a second reconciliation bill he has hinted at this fall?

Speaking of health care priorities, the Energy and Commerce Health Subcommittee will hold a July 16 hearing on the public health workforce, rural health, and over-the-counter drug legislation.  This will be the first hearing for the subcommittee since Rep. Morgan Griffith (R-VA) was selected as the Subcommittee Chair. Griffith has long shown interest in streamlining FDA processes, and he might prioritize legislation aimed at faster drug approvals, clarifying regulatory pathways, or encouraging domestic drug manufacturing to reduce foreign dependence.

There You Have It

Summer travel season is in full swing! Where are you traveling this summer?  Be on the lookout for our summer reading recs on LinkedIn!  Make it a great week!

 

Week Ahead: Fireworks and Finish Lines

Senate Republican leaders return to Washington this week with just enough time to pass reconciliation and get home to see 4th of July fireworks. But Congress and the administration also have to deal with the fallout from the bombing of Iran. There is certainly a lot going on in DC!  So, let’s get into it – welcome to the Week Ahead!  

The Administration  

The Centers for Medicare and Medicaid Services (CMS) has kicked off its own fireworks show by finalizing the 2025 Marketplace Integrity and Affordability Final Rule. The final rule largely retains the provisions of the proposed rule released in March, including shortening of the Affordable Care Act (ACA) open enrollment period and prohibiting ACA coverage for Deferred Action for Childhood Arrivals (DACA) recipients.  

However, the rule also finalizes other parts of the proposal on a temporary basis, including several provisions strengthening income eligibility requirements. Why would CMS do that? 

According to reports, by sunsetting some of the rule’s provisions, Congress could get “budget credit” if these provisions are included in the final reconciliation bill being debated in Congress.  The Congressional Budget Office (CBO) previously estimated that many of these same provisions in the House-passed version of the reconciliation bill would save $101 billion over ten years.  

The Senate draft did not include these provisions, but having an extra >$100 billion of “walking around money” could be very useful to Republican leaders either to reduce the overall cost of the bill or mitigate the need for savings from other controversial provisions like Medicaid provider taxes or state directed payments.  

We expect CMS to finalize several other final rules over the next month, including rules setting Medicare payment rates for the coming year. These rules will set the stage for how Medicare reimburses different providers and services.  

The Senate 

Senate Republicans are feeling the heat, and it’s not just because of the temperature. Ever since the Senate Finance Committee released its reconciliation text on June 16, several Republican Senators have raised concerns about those provisions. For example, there are concerns about proposed reductions in the use of provider taxes to 3.5% by 2031 for Medicaid expansion states, as well as an annual 10% reduction in state directed payments until they match Medicare rates. This group includes Sens. Josh Hawley (R-MO), Jim Justice (R-WV), Lisa Murkowski (R-AK), and Susan Collins (R-ME). When you add in Senators such as Sens. Ron Johnson (R-WI) and Rand Paul (R-KY), who have raised concerns about the bill’s impact on the deficit, you are up to six Senators with major concerns over the current draft.  Remember, Republicans can only afford three no votes and still pass the reconciliation bill. That’s certainly enough to make Senate Republican leadership sweat.  

That said, conversations are continuing to address these Medicaid concerns. For example, Sen. Hawley has been pitching a return to the House-passed moratorium on new provider taxes and changes to state directed payments with additional guarantees that existing rates would be grandfathered in. Additionally, there have been discussions about creating a fund to help rural hospitals survive any changes to provider taxes or state directed payments. Something will need to be done to ensure the bill doesn’t burn up on the Senate floor.  

In non-reconciliation news, the Senate Committee on Health, Education, Labor, and Pensions (HELP) is scheduled to consider the nomination of Dr. Susan Monarez to be the Director of the Centers for Disease Control and Prevention (CDC) on June 25. Expect this hearing to feature fiery remarks about the removal and replacement of the entire CDC’s Advisory Committee on Immunization Practices (ACIP) by Health and Human Services Sec. Kennedy.  

Other Health Care Hearings  

  • June 25: Senate Aging Committee hearing on sports medicine’s role in older Americans’ health  
  • June 25: Senate VA Committee hearing on the Veterans Crisis Line  

The House 

House Speaker Mike Johnson (R-LA) is prepared to cancel the House’s upcoming recess if it means there is a chance that the reconciliation bill could be sent to President Trump’s desk before July 4th. But even with additional time, navigating the various factions within the House GOP caucus will be more difficult than leaving the National Mall after the fireworks end. That’s because, in addition to addressing concerns from members about Medicaid or the deficit, the Speaker also has to find a way to address concerns from House Republicans on the SALT Caucus 

The Senate reconciliation bill’s dropping of the SALT deduction cap from $40,000 to $10,000 is an insult to the SALT Caucus GOP members. Senate Republican leaders say their amount is a placeholder amount for negotiations, but it’s hard to see how that number makes GOP SALT Caucus members excited to come to the table.  

Meanwhile, the House Budget Committee will be wading into the debate over Medicaid work requirements at a June 25 hearing. While not specifically mentioning Medicaid in the announcement, we expect Republicans to use the hearing as a platform to argue in support of provisions of the reconciliation bill that implement work requirements for certain individuals enrolled in Medicaid and the Supplemental Nutrition Assistance Program. Expect Democrats to use their time to highlight what they argue will be the detrimental effects of such policies on beneficiaries, although they have yet to name a witness for the hearing.  

Other Health Hearings  

  • June 23: House Appropriations Committee continued markup of FY 26 Ag-FDA bill 
  • June 24: House Energy and Commerce Health Subcommittee hearing on FY 26 HHS budget  
  • June 25: House Ways and Means Health Subcommittee hearing on digital health 

There You Have It 

June 20 marked the Summer Solstice and First Day of Summer for the Northern hemisphere, otherwise known as the longest day of the year. How did you make use of the extra daylight? Let us know. Make it a great week!  

Week Ahead: Reconciliation Roulette

It’s a high-stakes week in Washington as Senate Republicans work furiously to finalize their budget reconciliation bill and as Republicans’ self-imposed July 4 deadline gets ever closer. Meanwhile, the Trump administration continues to work on drug pricing reform. Let’s get into it. Welcome to the Week Ahead! 

The Administration  

The Trump administration is looking at advancing its “Most Favored Nation” (MFN) policy as a demonstration through the Center for Medicare and Medicaid Innovation (CMMI). The proposal would tie the price of blockbuster drugs in the U.S. to the lowest prices paid in OECD countries, adjusted for rebates.  

The possibility of this new model comes as manufacturers were dealt an ultimatum: cut prices voluntarily by June 12 or face regulatory roulette. The price benchmark? The lowest among countries with a GDP per capita of at least 60% of the U.S.—a move that could shake up the entire pricing deck. Discussions among pharmaceutical executives and administration officials are taking place behind closed doors. However, the policy is still being shuffled, and no one is yet sure who will emerge with the winning hand

But that’s not the only game in town. The Trump administration is also seeking to turn the tables on foreign players who they feel are freeloading off U.S. innovation. Specifically, they’re eyeing trade tools such as those found under  Section 301 of the Trade Act of 1974.  Additionally, a report is expected soon on an investigation into the effects of pharmaceutical imports on national security (aka a “Section 232 report”). Both of these actions could result in the administration dealing out tariffs or other retaliatory actions against countries with strict price controls.  

The Senate  

Over in the Senate, the stakes couldn’t be higher as lawmakers head into what’s shaping up to be a critical week for meeting the self-imposed July 4 deadline for passage of a budget reconciliation bill. Senate Finance Committee Chair Mike Crapo (R-ID) is set to present on the committee’s provisions, including the tax and health care provisions, on June 16 at a GOP conference meeting. Meanwhile, the Senate Parliamentarian is playing the role of dealer, making sure every provision of the legislative text comports with the complex Byrd Rule. The July 4th recess is looming over the whole game, and lawmakers are racing the clock to wrap negotiations before the fireworks fly.  

One of the biggest issues in the negotiations is over State and Local Income Tax (SALT) deductions. Negotiators are caught between a rock and a hard place: a $30,000 cap can’t clear the House, but a $40,000 cap can’t make it through the Senate. On one side of the table, you have blue state Republicans, like Rep. Mike Lawler (R-NY), threatening to vote no if the Senate does not preserve enough of a deduction. On the other side of the Capitol, Republican Senators, who don’t represent many constituents impacted by high state and local income taxes, but have voiced concerns over the house passed cap.  Will the Senate jam the House, or can they come to an agreement during a truncated conference committee process?  

For health care, many Republicans like Senators Josh Hawley (R-MO), Susan Collins (R-ME), Lisa Murkowski (R-AK), and Jim Justice (R-WV) are concerned about the Medicaid provisions, such as limits on provider taxes, work requirements, and new copays.  On the other side, Sens. Rand Paul (R-KY), Rick Scott (R-FL), and Mike Lee (R-UT) are wanting to up the ante on spending cuts. Senate Republican leadership can’t lose more than three members if they want to pass the bill.  

Some Republican members, such as Rep. Young Kim (R-CA), have a stake in both the SALT and Medicaid games. It’s possible that Senate Republican leadership tries to make reductions to SALT easier to swallow by pushing back work requirements or grandfathering existing provider tax rates. However, that will no doubt anger conservatives in both chambers. Balancing both interests has turned this into a real high-wire act, with leadership trying to keep the coalition together without losing key votes. Much like a table full of pros waiting for someone to blink, everyone’s watching for tells, backroom deals, and surprise plays that could shift the momentum before time runs out. 

The House 

The House may be in recess, but the players aren’t far from the table. House members are watching the Senate’s every move, trying to influence things, and getting ready to receive the Senate’s revised bill. Even Speaker Johnson is waiting to see how the Senate plays its hand and is constantly reminding the Senate that the House passed its version by a single vote. 

Meanwhile, the government funding for FY 26 remains in the air. The House Appropriations Committee has advanced legislation to fund the Department of Defense and the Department of Veterans Affairs. However, a June 11 Appropriations markup of the Ag-FDA funding bill ended after 11 hours when committee Chair Cole (R-OK) realized they wouldn’t be able to finish ahead of the scheduled markup of the defense bill due to numerous amendments that were filed.  The House also passed a rescissions package before leaving town with cuts to global HIV/AIDS prevention funding.  However, that’s for already approved funding and is considered a dead hand by many in the Senate, including some Republicans.  

There you Have It  

New NBA and Stanley Cup champions could both be crowned this week—who’s your pick to take it all? Make it a great week! 

Week Ahead: The Real Housewives of Pennsylvania Avenue?

In what seems like a premiere of the Real Housewives of Pennsylvania Avenue, Elon Musk and President Trump are splitting faster than members of Congress heading to recess. As Musk and Trump throw shade at each other, the Senate’s ‘Big Beautiful Bill’ might need a big, beautiful rescue plan. Let’s get into it. Welcome to the Week Ahead!  

The Administration  

The deadline is this week for the Centers for Medicare and Medicaid Services (CMS) request for information on regulatory burden, and the administration is looking for respondents to dish on how to best reduce the red tape. Health care groups have no shortage of ideas, but like a VIP party, we probably won’t see the guest list except for those who decide to share that they were there. And remember, this is just an RFI, not a new rule or regulation. The administration can decide to take suggestions or leave them as it suits them.  

Meanwhile, Office of Management and Budget (OMB) Director Russell Vought, has told the House Appropriations Committee not to expect more details about the President’s budget request and to work with what they’ve got when it comes to the President’s budget for fiscal year 2026. But it’s already June, and before you know it, summer will be over, and the September 30 deadline to pass FY 26 funding bills will be here. We are already seeing some House Republican appropriators express concerns about the timeline. As summer drags on, that number of doubters could grow.   

The Senate 

Senate GOP leadership has one goal this week: get “pens down” on the Senate’s version of the One Big Beautiful Bill Act and start the next scene. But let’s be real—they’re still far from a finished product. And now what GOP leaders had hoped would be a steady march toward passage is a lot like a group dinner gone wrong. Some Committees are releasing legislative text, but no one agrees on the guest list, the menu, or the bill. 

Republicans are looking at changes to the health section, including  the possibility of adding changes to Medicare Advantage (MA) to help reduce the overall cost of the bill. Specifically,  the Senate is looking at dialing back coding intensity adjustments that could net significant savings. Other potential changes to the menu could include: 

  • Pushing back the December 31, 2026 effective date for new Medicaid work requirements, The House Energy & Commerce Committee had set the effective date for January 1, 2029 in its version of the bill.  
  • Giving states more time before they are required to conduct Medicaid eligibility checks every 6 months instead of the current every 12 months for the expansion population. Currently, that provision is set to go into effect for renewals scheduled on or after December 31, 2026.  
  • Extending the effective date for ending the incentives for states to expand Medicaid coverage. That date is currently set for January 1, 2026. 

In addition to these considerations, the Senate could bend to pressure to weaken the House-passed bill’s prohibition on new provider taxes and its freeze on existing provider taxes. Senators from states with provider taxes in place have complained that these provisions leave a bitter aftertaste in their mouths.  

The trick will be making sure the menu remains appealing to diners in both the House and Senate, some of whom have very different tastes. The menu could get a little less salty if Senate Republicans decide to trim the current state and local tax (SALT) deduction. The House SALT Caucus is demanding respect and threatening to walk if their concerns are not addressed in the final cut.  

Will we see a markup?  With all the Republican talk of using regular order, so far, the negotiations on tax and health care have been only within their own party.  Senate Minority Leader Chuck Shumer (D-NY) and Finance Ranking Member Ron Wyden (D-OR) sent a letter demanding a markup, which suggests Finance may not have one. Democrats are ready to host the reunion and get the drama out in the open.  

As for the rest of the Senate cast, they’re trying to act calm and collective, but the group chat is full of shade. Negotiations are happening behind closed doors, but the energy is “we’re not far apart” one minute and “we’re done here” the next. 

And don’t forget the guest stars. Several fly-ins are happening this week, including key Medicaid constituencies such as nursing homes and children’s hospitals. They’re storming the Hill like Housewives entering a new season—scripted talking points, matching outfits, and a deep fear of being left out of the final edit. 

Senate Health Hearings 

  • June 4: Senate Appropriations Labor-HHS Subcommittee hearing on FY 26 NIH Budget Request 

The House 

Over in the House, things are a little quieter—but not without drama. The Energy and Commerce Health Subcommittee is having a hearing on domestic manufacturing and the health care product supply chain on June 11. The hearing is expected to provide a high-level overview of a broad range of supply chain concerns, and explore the underlying background and contributing factors that have led to current disruptions—emphasizing a deeper understanding of the “what” and the “why” behind these issues. Expected topics include drug shortages, tariffs, international reference pricing, inspections of foreign drug manufacturing sites, and more.  While we don’t expect the majority to push a proposal or fix it at the hearing, we do expect members to offer plenty of ideas.  

Meanwhile, the House is watching the Senate with the same energy as a reunion special audience—waiting to see who flips, who cries, and whether groups such as the Freedom Caucus or SALT Caucus will throw the whole thing off track.  Everyone’s whispering about it like it’s a secret affair we’re all pretending not to know about.  

Additionally, a rescissions package that bill is causing slashes funding to HIV/AIDS programs like PEPFAR is expected on the floor this week. This will cause an uproar among public health groups, as well as both Republican and Democratic representatives who have been supportive of the program.  

The reintroduction of the Improving Access to Medicare Coverage Act is likely this week. This bipartisan bill would count patients’ time spent under observation status in a hospital towards the three-day stay required for Medicare coverage of care in a skilled nursing facility. CMS had waived the requirement during the COVID-19 public health emergency (PHE), but with the PHE in the rearview mirror, supporters are hoping lessons learned from the PHE will help draw new interest and a willingness to explore including the legislation in a must-pass health care package this Congress. 

Other Health Hearings This Week  

  • June 10: House Appropriations Committee MILCON-VA Subcommittee Markup of FY 26 Allocations 
  • June 11: House VA Oversight Subcommittee Legislative Hearing on H.R. 3482 Veterans Community Care Scheduling Improvement Act and H.R. 3494, VA Hospital Inventory Management System Authorization Act 
  • June 12: House VA Health Subcommittee Legislative Hearing on H.R. 785, The Representing Our Seniors at VA Act of 2025; H.R. 2068, The Veterans Patient Advocacy Act; H.R. 2605, The Service Dogs Assisting Veterans (SAVES) Act; H.R. 3400, The Territorial Response and Access to Veterans’ Essential Lifecare (TRAVEL) Act of 2025; H.R. 3643, The VA Data Transparency and Trust Act; H.R. 1404, The CHAMPVA Children’s Care Protection Act of 2025; and H.R. 2148, The Veteran Caregiver Reeducation, Reemployment, and Retirement Act 

There you Have it 

A reminder that Father’s Day is June 15! Chamber Hill Strategies wishes all the Dads out there a very Happy Father’s Day.